Highlights
- 750,000 patients die of stomach cancer each year after developing the disease. The main cause of this cancer is thought to be Helicobacter pylori (H. pylori) bacteria
- Gastric cancer is one of the five most fatal types of cancer
- This bacteria has been known destroy the stomach's protective layer, it secretes a protease enzyme called HtrA to penetrate these layers
Helicobacter pylori, which cause gastric cancer, secretes an enzyme, called HtrA, to penetrate stomach's protective layer found a study published in Cell Host & Microbe journal.
Gastric cancer, also known as stomach cancer is one of the five most fatal types of cancer. According to the World Health Organization (WHO), around 750,000 patients die annually of this disease.
Gastric Cancer
Stomach (gastric) cancer develops from the stomach lining. It is the third most common cause for cancer related deaths.
Advertisement
‘Helicobacter pylori secretes an enzyme called HtrA, which penetrates to the stomachs protective layer. This is the first step towards gastric cancer starting to develop.’
Tweet it Now
At present, there are no effective therapies for gastric cancer and growing spread of antibiotic resistance is further complicating treatment of the infection. Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have now identified two mechanisms through which this bacterium can cause gastric cancer. Their findings could result in the development of new therapeutic approaches.
The international team of scientists headed by Dr. Nicole Tegtmeyer of the Chair of Microbiology at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) investigated how bacteria destroy the stomach's protective layer. This protective layer is composed of densely packed epithelial cells that protect the stomach against the effects of gastric acid.
![Test Your Knowledge on Gastric Cancer]( "Test Your Knowledge on Gastric Cancer")
cabbages and potatoes reduce the risk of gastric cancer. Studies such as these aid in controlling the incidence of this type of cancer.
The researchers have now discovered that H. pylori secrete an enzyme, a protease called HtrA, which it uses much like a weapon to penetrate this protective layer. HtrA cleaves the three proteins occludin, claudin-8, and E-cadherin, rupturing the layer of epithelial cells.
As a result, the H. pylori bacteria can access deeper, normally pathogen-free tissue layers, and inflict further damage. This is the first step towards gastric cancer starting to develop.
This first phase, however, is followed by one that is even more dangerous, as the team discovered.
Needle-like protrusions, termed type IV secretion systems, are activated and function as 'molecular syringes.' Using a receptor-dependent mechanism, these inject a bacterial toxin, the CagA protein, through the basolateral membrane of the host cells. The injected CagA subsequently reprograms host cells, making them potentially cancerous.
Another effect of this protein is that it prevents the human immune system from recognizing and eliminating the bacteria - a crucial mechanism for the long-term survival of H. pylori in the human stomach.
Dr. Tegtmeyer expects these findings will make it possible to develop important new antibacterial therapeutic approaches, as HtrA and CagA are ideal novel drug targets. The team has already started to test specific HtrA inhibitors. "We hope that suitable active agents can either completely prevent infection or inhibit the injection of CagA," explains Tegtmeyer.
Reference
Source: Eurekalert
Test Your Knowledge on Gastric Cancer
cabbages and potatoes reduce the risk of gastric cancer. Studies such as these aid in controlling the incidence of this type of cancer.
Advertisement
The researchers have now discovered that H. pylori secrete an enzyme, a protease called HtrA, which it uses much like a weapon to penetrate this protective layer. HtrA cleaves the three proteins occludin, claudin-8, and E-cadherin, rupturing the layer of epithelial cells.
As a result, the H. pylori bacteria can access deeper, normally pathogen-free tissue layers, and inflict further damage. This is the first step towards gastric cancer starting to develop.
This first phase, however, is followed by one that is even more dangerous, as the team discovered.
Needle-like protrusions, termed type IV secretion systems, are activated and function as 'molecular syringes.' Using a receptor-dependent mechanism, these inject a bacterial toxin, the CagA protein, through the basolateral membrane of the host cells. The injected CagA subsequently reprograms host cells, making them potentially cancerous.
Another effect of this protein is that it prevents the human immune system from recognizing and eliminating the bacteria - a crucial mechanism for the long-term survival of H. pylori in the human stomach.
Dr. Tegtmeyer expects these findings will make it possible to develop important new antibacterial therapeutic approaches, as HtrA and CagA are ideal novel drug targets. The team has already started to test specific HtrA inhibitors. "We hope that suitable active agents can either completely prevent infection or inhibit the injection of CagA," explains Tegtmeyer.
Reference
- Nicole Tegtmeyer, Silja Wessler, Vittorio Necchi, Manfred Rohde, Aileen Harrer, Tilman T. Rau, Carmen Isabell Asche, Manja Boehm, Holger Loessner, Ceu Figueiredo, Michael Naumann, Ralf Palmisano, Enrico Solcia, Vittorio Ricci, Steffen Backert11,'Correspondence information about the author Steffen Backert. Helicobacter pylori Employs a Unique Basolateral Type IV Secretion Mechanism for CagA Delivery, Cell host and microbe(2017)DOI:http://dx.doi.org/10.1016/j.chom.2017.09.005
Source: Eurekalert
Stomach Cancer | Gastric Cancer - Video
Medindia provides informative interesting health videos for all major type of disease; tap here to know more about the gastric cancer health video to get information.
Advertisement
 Infographics on Stomach CancerStomach cancer or gastric cancer is diagnosed late, stomach cancer infographic combines information with statistics to create awareness about the disease. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
